Objective: To investigate involvement of the integrin alpha 5 subunit of the classical fibronectin receptor in cartilage chondrolytic activities of fibronectin fragments (Fn-f).
Introduction
Fibronectin (Fn) is an extracellular matrix protein that is easily degraded into fragments (Fn-fs) by many different types of proteinases. In synovial fluids of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) [1] [2] [3] [4] [5] , levels of Fn-fs are greatly enhanced. Further, the Fn content and Fn synthesis rates within the cartilage are elevated both in human OA cartilage 6, 7 , in a canine surgical model of cartilage damage 8, 9 or with altered biomechanical loads [10] [11] [12] . These conditions ultimately could provide higher levels of Fn-fs. The high levels of Fn-fs in synovial fluids or within the cartilage might be predicted to have a deleterious effect on the knee joint cartilage, since Fn-fs can up-regulate catabolic cytokines 13, 14 and matrix metalloproteinase (MMP) expression in articular cartilage [15] [16] [17] and temporarily suppress synthesis of proteoglycan (PG) 18-20 . The result is severe and irreversible cartilage damage to bovine explants in vitro 18, 19, 21 and to rabbit knee joint articular cartilage when Fn-fs are intraarticularly injected 22, 23 . The Fn-fs appear to exert their action by binding chondrocytes 21 and enhancing release of the catabolic cytokines, TNF-, IL-1 , IL-1 and IL-6 13, 14 . The cytokines are mostly responsible for the subsequent stromelysin-1 (MMP-3) induction and the suppression of PG synthesis observed 14 . Several MMPs are up-regulated, including an aggrecanase activity 22, 23 , all of which collectively cause cleavage at a classical MMP site as well as an 'aggrecanase site', a second physiologically relevant cleavage site. Interestingly, these proteases and cytokines can increase the Fn-f pool further, since Fn-fs easily can be generated by addition of MMP-3 or IL-1 to cartilage 24 . The major characteristics of this model of cartilage damage have been reviewed 25 . We have proposed that the Fn-fs operate through the Arg-Gly-Asp-Ser dependent alpha 5 beta 1 integrin receptor, based on observations that antibodies to this receptor suppress PG synthesis as do Fn-fs (unpublished), and analog peptides of the Arg-Gly-Asp-Ser integrin-binding sequence block activities of the Fn-fs 26 . We have shown that addition of Fn-fs to living chondrocytes, followed by addition of chemical cross-linker, results in cross-linking of Fn-fs to the alpha 5 protein (submitted). Since the crosslinking studies only could suggest proximity but not active involvement of this subunit, our objectives here were to determine whether the Fn-fs mediated their effects through the alpha 5 subunit.
Materials and methods
Except where noted, all common chemical reagents and chromatography resins were from Sigma Chemical Co. (St Louis, MO). Dulbecco's modified Eagle's medium (DMEM) and penicillin-streptomycin were from Sigma Chemical Co. The Enhanced Chemiluminescent (ECL) kit used for Western blot detection was the Super Signal Chemiluminescent Substrate kit for HRP from Pierce Chemical Co. (Rockford, IL). [ . RNA isolation supplies were from Life Technologies (Grand Island, NY). Supplies for RT-PCR were from Perkin Elmer (Foster City, CA). PCR products were purified using a Wizard PCR prep DNA purification kit (Promega, Madison, WI). cDNA was sequenced by Sequetech Corporation (Mountain View, CA). Polyclonal affinity purified rabbit antibody to integrin alpha 5 (CDw49e) (with cross-reactivity to human, bovine, chicken, rat and mouse) was from Chemicon International Inc. (Temecula, CA). E coli LPS (026-B6) and polymixin B sulfate were from Sigma Chemical Co. (St Louis, MO). Mouse antihuman integrin alpha 5 beta 1 monoclonal antibody (cat# MAB1969) was from Chemicon International Inc. (Temecula, CA). Recombinant human IL-1 was from R&D Systems (Minneapolis, MN).
ISOLATION OF FN AND FN-FS
Fn was isolated from human plasma by adsorption to gelatin-Sepharose and elution with 3 M urea 15 . A wellcharacterized amino-terminal heparin-binding 29 kDa Fn-f and a 50 kDa gelatin-binding Fn-fs were isolated by sequential cathepsin D and thrombin digestion of Fn as described 15 . A mixture of carboxyl-terminal 140 kDa and smaller Fn-fs not contained in the 29 kDa or 50 kDa Fn-fs were isolated by cathepsin D digestion as described 15 and were used without further purification. The mixture of 140 kDa and smaller Fn-fs is referred to as the 140 kDa Fn-f. The three Fn-fs solutions represented the entire polypeptide chain of Fn. All Fn-f solutions were dialysed against 20 mM phosphate buffer, pH 7.4, containing 150 mM NaCl, passed through De-toxi Gel from Pierce Chemical Co. (Rockford, IL) to remove trace endotoxins and sterile filtered prior to use. Periodic testing for endotoxin with the endotoxin kit from Sigma Chemical Co. typically showed insignificant levels of endotoxin of less than 50 pg per mg of Fn-f. As an additional verification that LPS does not play a role in Fn-f mediated activities, polymixin B sulfate, which inactivates LPS, was added at a final concentration of 10 g/ml to Fn-f treated cultures in DMEM. The Fn-f PG degradation rates (determined as described below) without and with polymixin treatment, respectively, were 3.95±0.4 and 4.06±0.28 g PG/mg cartilage/day. Also, polymixin did not alter significantly the ability of Fn-fs to suppress PG synthesis. Thus, the activities of the Fn-f solutions could not be due to endotoxin contamination.
EXPLANT CARTILAGE CULTURES
Culturing of articular cartilage slices from adult (18-20 months of age) bovines was performed as described 15, 18 in DMEM containing 50 U/ml penicillin/streptomycin with 10% serum/DMEM with 50-80 mg cartilage in 2 ml of media. Each datum was a mean and the S.D. values were based on at least three similar tissue culture wells. For each major parameter at least three separate harvests were studied, with a total of over 15 harvests for the collective study.
ISOLATION OF CHONDROCYTES FOR MONOLAYER CULTURES
Articular cartilage was removed aseptically from the metacarpophalangeal joints of 18-20-month-old bovines, the cartilage tissue was subjected to a 90 min pronase (Calbiochem, San Diego, CA) digestion followed by an 18 h collagenase P (Boehringer Mannheim, Indianapolis, IN) digestion in DMEM/5% FBS as described 17 . The resulting cell suspension was washed repeatedly, cell counted and the cells were plated at 0.75 million cells/well in a 24-well plate in DMEM/10% FBS. The media were changed every other day and serum-free cultures were started on day 3 after washing with 8-10 volumes of DMEM.
DESIGN OF ANTI-SENSE OLIGOS
Antisense (ASO), sense (SO) and scrambled (SCO) oligos derived from the sequence of the alpha 5 subunit of the Fn integrin were purchased from Integrated DNA Technologies, Inc. (Coralville, IA). The phosphorthioate analogs, which penetrate cell membranes better, have an increased affinity for the target and have slower rates of degradation by nucleases, were utilized. The antisense sequence was derived from the coding sequence (bases 121-144) of the bovine alpha 5 subunit (Accession # U10866) 27 . The ASO sequence was 5′-CTCTGCCTCGTA GGCGCCACCCTC-3′. The negative control SO sequence was homologous to the mRNA sequence: 5′-GAGGG TGGCGCCTACGAGGCAGAG-3′. The negative control SCO sequence had the same G:C content as the antisense sequence. The scrambled sequence, GAGGTGCGGCG CCAGAACGTGCAG, was not predicted to bind to any known sequence (by Blast analysis). All sequences were checked with the EMBO database for uniqueness and all oligos were HPLC-purified.
ANALYSIS OF ALPHA 5 
MRNA
Chondrocytes from bovine articular cartilage treated with different parameters were grown in monolayers and then lysed directly in a culture dish by use of Trizol Reagent as described by the supplier (Life Technologies, Grand Island, NY). This protocol involves Trizol/chloroform treatment, followed by isopropyl alcohol precipitation and ethanol washes of the resultant pellet. GeneAmp RNA PCR kit components (Perkin Elmer, Foster City, CA) were used to reverse transcribe the isolated RNA to cDNA, according to the manufacturer's protocol. Each sample solution for reverse transcription contained 5 mM The amplified PCR product was subjected to electrophoresis on a 1% agarose gel, the gel stained with ethidium bromide and visualized using Quantity One software on a Flour-S Multimager (BioRad Laboratories, Richmond, CA). After amplifying the PCR product further, the PCR products were purified using a Wizard PCR prep DNA purification kit (Promega, Madison, WI). The purified DNA product was then analysed on an agarose gel to verify purity and the concentration of the purified DNA determined by reference to the molecular standards. A solution of purified cDNA, at about 5 ng/ l, was submitted for single primer extension sequencing, in two directions, using at 15 M the alpha 5 An aliquot of cell lysate of 10 l (typically 1-2 million cells) was applied to a 7.5% acrylamide SDS gel and the gel blotted onto nitrocellulose for 18 h at 30 V, followed by 1 h at 90 V. The blot was then treated with 3% BSA in 50 mM phosphate buffer, pH 7.4, containing 150 mM NaCl, for 1 h to block non-specific absorption sites. The blot then was incubated with 7 g/ml (1 to 300 dilution) of rabbit antialpha 5 antibody for 1 h, followed by six washes with the phosphate buffer (15 min per wash). The blot was then reacted with HRP conjugated goat antirabbit IgG (Sigma # A-0545; 1:40,000 titer by direct ELISA) for 1 h (1:20,000 fold dilution of 1 mg/ml with 0.05% Tween 20, 1% BSA, in the phosphate buffer). After washing six times with phosphate buffer-Tween 20, the blot was reacted with ECL premixed substrate solution (Pierce Chemical Co.) for 1 min then applied to the membrane. The blot was then placed in a plastic membrane protector and subjected to autoradiography for up to 30 s.
RATES OF SODIUM 35 S-SULFATE AND 35S-METHIONINE/CYSTEINE

INCORPORATION
Sulfate incorporation was used as an index of synthesis of sulfated PG as described 18, 19 . Briefly, rates were measured using a 2-h pulse with 10 Ci/ml of 35 S-sodium sulfate in 1.5 ml of 10% serum/DMEM, followed by a 2-h cold chase with 10% serum/DMEM. Slices were extracted with 1 ml of 4 M Guanidine HCl, 0.1% Triton X-100, 10 mM EDTA, 100 mM sodium acetate, pH 5.5, for 16 h at 9°C, followed by exhaustive dialysis of the extracts against 10 mM EDTA-water, adjusted to pH 5.5. The amount of label was expressed as dpm/mg wet weight cartilage, converted into % of control values and means and S.D. values were reported from 3-6 similar culture wells. For comparison of experimental data to control data, datasets were subjected to Dunnet analysis to obtain P values, where a P value <0.05 was considered significant. Rates of protein synthesis were measured using 10 Ci/ml 35 Smethionine/cysteine for a two-hour labeling in the same way as 35 S-sulfate incorporation was measured above.
RATES OF PG RELEASE INTO MEDIA OF CARTILAGE CULTURES EXPOSED TO FN-FS
Rates of release of degraded PG from cartilage explants into the conditioned media were measured as Fig. 1 . Effect of phosphorthioate oligos on alpha 5 mRNA as determined by RT-PCR-chondrocytes from bovine articular cartilage treated with different parameters were grown in monolayers in the presence or absence of oligonucleotides for 3 days in serum free conditions and then lysed directly in a culture dish by use of Trizol Reagent. The isolated RNA was reverse transcribed using a GeneAmp RNA PCR kit. The resultant cDNA subsequently was amplified using AmpliTaq DNA Polymerase and the product subjected to electrophoresis on a 1% agarose gel at 120 V for 1.5 h and the gel stained with ethidium bromide and visualized using Quantity One software on a Flour-S Multimager (BioRad Laboratories, Richmond, CA). Each lane represents 50 ng of amplified PCR product. Lanes on left are of GADPDH amplification and on right, of alpha 5 . Shown are lanes for SO (sense oligo), ASO (antisense oligo) and SCO (scrambled oligo) treatment. For some lanes, divider lanes were used to compensate for heavy protein loading and the divider lanes removed to allow merging of the lanes for the final image.
described 15, 21 , using the dimethylmethylene blue (DMB) dye-binding assay. Briefly, a volume of 0.8 ml DMB reagent, prepared as described 28 , was mixed with 190 l of 1.37 M Guanidine HCl and 10 l of test sample and after 2 min, a spectrophotometer was used to determine absorbances at 525 and 595 nm, using water as a blank. The ratios of 525 nm absorbance over 595 nm absorbance were used to establish a standard curve with purified PG and a standard curve of 0.5 to 3 g/ml purified bovine PG used to estimate PG contents in the papain digests. The PG contents per mg wet weight cartilage for each of three culture wells per time point were then graphed vs days and the data subjected to linear regression to obtain slopes and S.E.M. values. Typically, assays were performed of triplicate wells per time point at days 1, 3, 5, 7 and 9, resulting in a 15-point curve for linear regression analysis. The slopes are reported as rates of g PG/mg wet weight cartilage/day. The regression coefficients were typically greater than 0.90. Rates were compared to the respective controls using Dunnet analysis to obtain P values.
PG-CONTENT OF CARTILAGE
The total amount of g PG/mg wet weight cartilage was determined by assays with DMB reagent after treatment of 50-80 mg of cartilage in 1.0 ml of 50 mM phosphate buffer, pH 6, containing 10 mM EDTA and 10 mM cysteine, with 50 g/ml papain for 16 hours at 65°C as described 20 .
TESTS OF OLIGOS
To test effects of oligos on chondrocytes, cells were plated into 24-well plates in 10% serum/DMEM and after typically 3 days, the medium was changed to DMEM and oligos added from a 0.1 mM stock solution in DMEM. After 2 days, the media were changed, fresh oligos added as well as Fn-fs and assays begun. Three wells were used for each datum and each experiment was performed at least three times. Therefore, the means and S.D. values reported are from at least nine culture wells from at least three different chondrocyte culture preparations. The 29 kDa Fn-f was used in all cases at 1 M, while the 50 kDa and 140 kDa Fn-fs were used at 2 and 3 M, respectively. This was done since the 29 kDa Fn-f is the most active and the lower activity of the others makes assays of them at 1 M more error prone. In each experiment, controls of SCO, or SO or ASO alone were always run, in order to validate comparisons to experiments of oligos added in combination with the Fn-fs. Pairwise comparisons of experimental data to control data were performed by Student's t-test analysis.
To test effects of oligos on cartilage explants, 1 day after establishing the culture, the medium was changed to DMEM and oligos added. After 1-5 days, the medium was changed, oligos added back with Fn-fs and aliquots of the media drawn every day for up to 5 days and PG content determined for each time point. These experiments were performed with at least three different cartilage preparations. Therefore, for 5 days per kinetic rate and five different cartilage preparations, the mean and S.E.M. values were based on at least 25 points. Oligos were tested on at least three tissue preparations from separate harvests. As above, for each experiment a full set of controls with each Oligo added alone were tested. Statistical analysis was based on the Student's t-test.
Results
THE ASO REDUCED MRNA EXPRESSION AND PROTEIN LEVELS OF THE ALPHA 5 SUBUNIT
The effect of the oligos on mRNA levels of the alpha 5 subunit was tested first, after a 2-day incubation with 1 M oligos. This length of incubation later was found to be The effect of the oligos on protein levels of the alpha 5 subunit in cartilage tissue was tested next. The results from three separate gels were averaged. Figure 2(a) is a representative gel and shows that 1 M ASO effectively decreased alpha 5 protein in explant cultures as compared with SCO or SO. ASO decreased alpha 5 protein levels to 33±9% of control SCO levels (P=0.002; student's t-test) and 24±5% (P=0.001; Student's t-test) of control SO levels. Combinations of Fn-f with SCO and SO resulted in similar protein expression as SCO or SO alone. However, the combination of ASO with Fn-f resulted in alpha 5 protein levels lower than with ASO alone, perhaps due to an additional effect of the Fn-f on cartilage tissue. The ASO also decreased levels to 31±6% and 42±9%, as compared to SCO in two other experiments performed with different cartilage harvests.
Similar analysis was performed on monolayer cultures. Figure 2(b) is a representative gel. The statistics were based on averaging of densities of three different gels. The analysis showed that the alpha 5 protein levels in SCO-and SO-treated cultures were not significantly different, however ASO decreased protein levels to 44±4% of SCO control alone levels (P=0.007) and to 41±11% of SO alone controls (P=0.005). ASO also decreased protein levels in the presence of Fn-f (ASO+f) to 37±7% of SO levels (P=0.002). These significant effects of ASO were observed in two other experiments with different chondrocyte harvests. S sulfate. After 2 h, the cartilage was recovered, weighed and extracted and the extracts dialysed exhaustively against water. After scintillation counting, the cpm were expressed as dpm/mg wet weight cartilage. Designations are: SC for SCO (scrambled oligo); S for SO (sense oligo); AS for ASO (antisense oligo). Numbers in front of oligos refer to M concentrations.
P values of <0.05 or <0.01 are designated as * and **, respectively. Comparisons were made to Fn-f alone as control.
ASO WAS ALSO EFFECTIVE IN DECREASING PG SYNTHESIS SUPPRESSION AND GENERAL PROTEIN SYNTHESIS IN CULTURED
CARTILAGE
The effects of oligos on blocking Fn-f mediated PG synthesis suppression was tested next in cartilage explants. Cartilage was incubated with 1 M oligos for periods of 1, 2 or 5 days, prior to addition of Fn-fs in order to define the optimal conditions. A 2-or 5-day treatment with ASO blocked Fn-f mediated PG synthesis suppression to the same extent, while the effect at 1 day was much less (data not shown). Therefore, the effects at 2 days and of varying concentrations of oligos were studied. Figure 3 shows that concentrations of SO, SCO or ASO as high as 5 M, did not alter significantly the rates of PG synthesis as compared with the control. The addition of the 29 kDa Fn-f significantly (P<0.01) suppressed PG synthesis to 40% of the control level, while 1 or 5 M SO and SCO did not significantly block the action of the 29 kDa Fn-f. However, addition of ASO at a concentration as low as 10 nM significantly decreased Fn-f activity (P<0.01). In other experiments, the ASO was removed from the preincubation when the 29 kDa Fn-f was added, resulting in a return to 46±9% PG synthesis suppression after 1 day. This suggested that the effect of the ASO effect could be reversed within 1 day. This also suggested that the ASO did not cause irreversible cytotoxic effects.
The ASO was also signficantly effective in reversing PG synthesis suppression mediated by the 50 kDa and 140 kDa Fn-fs. The 50 kDa and 140 kDa Fn-fs alone, significantly (P<0.01) suppressed sulfate incorporation by 60% and 53%, respectively, while the ASO significantly (P<0.01) reversed the activities (data not shown). As shown earlier, the SCO and SO had no statistically significant effects alone, nor did they significantly block either Fn-f when the data were compared to data for the respective Fn-f alone. Figure 4 shows the effects of oligos on methionine/cysteine incorporation as a measure of total protein synthesis. Each of the Fn-fs suppressed protein synthesis in a statistically significant fashion (P<0.01) by 29-35%. However, the SCO and SO did not significantly reverse the Fn-f effect, while the ASO did so in each case.
ASO DECREASED FN-F MEDIATED PG SYNTHESIS SUPPRESSION IN MONOLAYER CULTURES
The oligos were tested next at 1 M for their effects on monolayer cultures after a 48 h pre-incubation time. Figure  5 shows that the 29 kDa, 50 kDa and 140 kDa Fn-fs alone, decreased sulfate incorporation by 31, 39 and 45%, respectively, which was statistically significant (P<0.01) in each case. Figures also shows that SCO or SO alone had no significant effect on PG synthesis nor did they significantly block the action of each Fn-f, when the data were compared to those for the respective Fn-f. However, as with monolayer cultures, 1 M ASO significantly (P<0.01) blocked the activity of each Fn-f.
ASO DECREASED THE KINETICS OF PG DEGRADATION IN FN-F CULTURED CARTILAGE
The effect on the kinetics of PG degradation was tested next. Cartilage was tested since monolayer cultures lacked 
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the extensive matrix required for this type of assay. Oligos were added to cartilage explants in DMEM for 2 days prior to addition of Fn-f and fresh oligos. Our initial studies showed that a 1-day pre-incubation with 1 M ASO decreased the degradation caused by 1 M 29 kDa Fn-f by 82±12 %, while a 2 and a 5 day pre-incubation, caused a respective 45±6 and 75±19% reduction. Therefore, we continued to use a 2-day pre-incubation. The effect of varying concentrations of oligos on the activity of the 29 kDa Fn-f was assayed. Figure 6 shows that the 29 kDa Fn-f significantly enhanced PG degradation (P<0.01, when compared with untreated control). Further, SCO and SO, from 0.1 to 5 M, had no significant effect on PG degradation when compared with controls (no Fn-f or oligo), nor did they significantly block the action of the 29 kDa, when compared to Fn-f alone. ASO over a range of concentration had no significant activity by itself, but it did significantly (P<0.01) block Fn-f activity at concentrations as low as 1 nM ASO, while 10 nM ASO blocked over 50% of the Fn-f activity. A concentration of 1 M was not significantly better than 0.1 M. In other experiments, a concentration of 0.2 M 29 kDa Fn-f was substituted for the 1 M, resulting in the same proportional effect of the ASO (data not shown). Figure 7 shows that the 50 kDa and 140 Da Fn-fs enhanced PG degradation rates. The effects were statistically significant P<0.01). Figure 7 also shows that 1 M ASO, but not SCO or SO, blocked the PG degradation caused by the 50 kDa and 140 kDa Fn-fs to a statistically significant degree, when the rates were compared with those for the respective Fn-f alone. Some of the above experiments were repeated in the presence of serum, which reduced the PG degradation rates of the Fn-f by 60±15% but only reduced the Fn-f activity by 21±3% activity. Thus, while the ASO was effective in serum, the relative efficiency was decreased two-fold as compared with serum-free conditions. In other experiments, cartilage treated with ASO only for days 0-3, followed by removal and addition of Fn-f, showed a recovery of degradative activity to 88±4% of the untreated value, suggesting a reversible effect.
For additional controls, the effect of ASO on other mediators of cartilage damage, antibodies to the alpha 5 beta 1 receptor, LPS and IL-1 , were tested. Table I shows that the antibody enhanced PG degradation, ASO signficantly blocked the enhanced degradation and SO was ineffective. LPS also enhanced PG degradation; however, the activity was not blocked by ASO or by SO. As expected, IL-1 enhanced PG degradation, but ASO and SO had no effect on this activity. Thus, the ability of ASO to block activity caused by antibodies to the alpha 5 beta 1 receptor confirms that the effect of the ASO on Fn-f mediated activities does occur through this receptor. The inability of ASO to block LPS activity confirms our other observations that Fn-fs do not mediate activity through LPS. The inability of ASO to block IL-1 activity suggests that under our conditions and during the time frame of our experiments, S sulfate. After 2 h, the cell layer was lysed and the lysates dialysed exhaustively against water. After scintillation counting, the cpm were expressed as dpm/well. P values of <0.05 or <0.01 are designated as * and **, respectively. Comparisons were made to Fn-f alone as control.
IL-1 activity is not mediated through generation of Fn-fs, which can induce IL-1 .
ASO ALSO DECREASED THE EFFECTS OF THE FN-F ON DECREASING THE PG CONTENT OF CULTURED CARTILAGE
Since PG degradation is only one marker of Fn-fmediated catabolism, the final PG content of the cultured cartilage was also measured, as a marker of effects on steady state levels of PG, which would also reflect possible involvement of the alpha 5 subunit in anabolism. Figure 8 shows that the oligos alone did not affect the PG content and that the 29 kDa Fn-f significantly reduced the PG content by 52%. Only ASO significantly reversed the Fn-f activity and did so at concentrations as low as 10 nM. Thus, the ASO blocked both Fn-f mediated PG catabolism and the overall effects on PG content.
Discussion
Our preliminary data suggested that the alpha 5 beta 1 RGDS dependent Fn receptor integrin is at least partly responsible for Fn-f activities. Although other alpha subunits have been detected on chondrocytes 29 , the alpha 5 beta 1 is the major Fn receptor 30 and has been shown to be involved in matrix interactions and proliferation of chondrocytes 31 . Antibodies to this receptor, as well as RGDS peptides also block adhesion of chondrocytes to Fn 32 . Further, this receptor is also involved in Fn-f mediated induction of MMPs in synovial fibroblasts 33 . We had observed that rabbit antihuman polyclonal antibodies to the alpha 5 beta 1 Fn receptor mimicked the activities of the Fn-f (unpublished) and that peptides resembling the receptorbinding sequence blocked the Fn-f activity 26 . Thus, the focus of this work was on the alpha 5 subunit.
Our objective here was to determine whether downregulation of the alpha 5 protein with ASO would block the action of the Fn-fs. It was assumed that down-regulation of this subunit would decrease levels of the alpha 5 beta 1 integrin. We focused on the alpha 5 subunit, rather than the beta 1 , because of the role of the alpha 5 in dictating specificity of the integrins. We chose to use an antisense approach to implicate a role for this subunit, since there is precedent for using ASO to probe integrin function. For example, ASO to beta 1 has been used to probe function in osteosarcoma cells 34 and to decrease focal contact formation on Fn and to alter cell morphology 35 . ASO to beta 1 or alpha subunits has been shown to decrease neural crest cell attachment to laminin or Fn substrata 36 and ASO to alpha subunits has been shown to inhibit neural crest cell adhesion to Fn and laminin 37 . Our studies focused on studies of bovine explant cultures, because the effects of the Fn-fs on these cultures have been more completely described by us than the effects on monolayer cultures. We also used mostly serumfree cultures because of a concern for interference by serum components, which we later verified. We studied two homogeneous Fn-fs, the amino-terminal 29 kDa and gelatin-binding 50 kDa Fn-fs, as well as a mixture, termed 140 kDa Fn-f, which contained all fragments carboxylterminal to the 29 kDa and 50 kDa Fn-fs. This mixture also contains the RGDS receptor-binding sequence. The effects of phosphorthioate oligos on mRNA levels of the alpha 5 subunit were tested first. Phosphorthioate protection was chosen to improve stability and penetration through membranes. Because of the possibility that the backbone of the phosphorthioate oligo itself may have secondary activities [38] [39] [40] , the ASO results were compared to that of the SCO and SO, as controls, rather than to Oligo minus experiments as controls. The analysis showed the ASO decreased alpha 5 mRNA and protein levels as compared with SCO and SO in both types of culture systems studied, cartilage explants and chondrocyte monolayer cultures.
The effect of ASO on PG synthesis was tested in both types of culture systems and shown to block the effect of all three Fn-fs on PG synthesis. The ASO was effective as low as 1 nM. The effect of the ASO on Fn-f mediated PG synthesis was reversible and thus, non-cytotoxic, was also dose dependent and required between 1 and 3 days for a maximal effect on cartilage tissue. The SCO or SO had no effect by themselves either on PG synthesis or in blocking the effect of the Fn-fs. The ASO also reversed the ability of the Fn-fs to suppress general protein synthesis, also suggesting a non-cytotoxic effect, and showed a reversible and a dose-dependent effect, which required between 1 and 2 days for maximal activity. In terms of PG degradation, the ASO, SCO and SO, by themselves, did not cause PG Bovine cartilage was cultured in DMEM and adjusted to oligo free or 1 M oligo conditions. After 48 h, fresh media were added which also included the test mediators. Aliquots of conditioned media were then withdrawn at various times and assayed for PG content. Rates of g PG/mg cartilage/day are shown without correction for untreated control (no mediator, no oligo) rate which was 1.09±0.11 (r 2 =0.91). The rate for Fn-f treatment was 3.95±0.4 (r 2 =0.92), which indicates this cartilage preparation was susceptible to Fn-f damage. Rates for SO and ASO treatment alone were 1.02±0.09 and 1.13±0.26, respectively. The rates and r 2 values were based on analysis of three culture wells for each of the five time points (days 1, 3, 5, 7 and 9) or in this case, N=15. The r 2 values for all slopes varied from 0.85 to 0.97 with an average of 0.90. *Indicates statistical significance at the level of <0.0001 when compared to respective no oligo control data (left column). degradation or block Fn-f mediated degradation. Only the ASO decreased the ability of the Fn-fs to both enhance the kinetics of PG degradation and to decrease the PG content of cultured cartilage. We also found that antibodies to the alpha 5 beta 1 receptor enhanced PG degradation while the ASO blocked this effect. This further confirms that our ASO sequence affected levels of the alpha 5 beta 1 receptor and indirectly confirms the role of this receptor in Fn-f activities since the ASO reduced both Fn-f and anti-receptor mediated activities. Others have also demonstrated that antibodies to the alpha 5 beta 1 mimick activities of Fn-fs and can also upregulate MMPs 33 . However, it should not be assumed that the antibody alters signal transduction similarly to the Fn-fs.
Our control experiments demonstrated several important points. Polymixin B sulfate, a blocker of LPS activities, did not block the Fn-fs activities, consistent with our observation that endotoxin levels in Fn-f solutions were insignificant. Further, ASO did not block the effect of LPS on PG degradation. Therefore, the Fn-f effects are not mediated through LPS contamination. We also found that ASO did not block the effect of IL-1 on PG degradation. The simplest interpretation is that IL-1 does not mediate its activities by enhancing degradation of cartilage Fn to generate Fn-f which would act on the alpha 5 beta 1 receptor. However, it is possible that generation of Fn-fs might occur too late in the IL-1 treated culture to contribute to the PG degradation. ASO might eventually decrease IL-1 mediated damage in much longer cultures than tested here. Since such long-term cultures would require additional characterization of secondary effects of the ASO, they were not included in this study.
The observation that a 5-day pre-incubation with ASO was less effective than a 3-day pre-incubation may suggest that down-regulation of one integrin may lead to up-regulation of another that could bind Fn-fs. For example, ligation of the alpha 5 beta 1 receptor is required for internalization of vitronectin by alpha V beta 3 41 . Also, both the alpha 5 beta 1 and alpha 4 beta 1 receptors are required for MMP gene expression induced by Fn-fs in fibroblasts 42 . Thus, while our data implicate the alpha 5 as a target of the Fn-fs, there may be other receptors that can either interact directly or indirectly with the Fn-fs or that can regulate the Fn-f activity by communicating with the alpha 5 subunit.
The demonstration that all three Fn-fs may mediate their activities through the alpha 5 -containing receptor is consistent with other observations that show the amino-terminus of Fn is also involved in Fn interaction with the cell membrane. For example, amino-terminal Fn-fs and antibodies to them inhibit pericellular matrix assembly 43 and block interaction of receptor with receptor antibodies 44 . The amino-terminal 29 kDa segment is required for formation of a Fn matrix and this segment binds only when the alpha 5 beta 1 integrin is present 45 . It has also been shown that the amino-terminal region of Fn binds cells only when both Fn and the Fn receptor are present. This has been interpreted to suggest that the amino-terminal region is required for binding to Fn fibrils 43 . Some of these observations have been reconciled into a model 46 in which the amino-terminal segment binds Fn fibrils, formed through domain-to-domain interactions [47] [48] [49] , which causes a conformational change that allows interaction of the cellbinding region (contained within 140 kDa Fn-f) with the receptor.
Based on the discussion above, it is possible that the Fn-fs added to chondrocytes might interfere with binding of native Fn to either the receptor or to fibrils or competitively displace Fn and thus alter the composition and signaling character of the pericellular matrix. The Fn-fs might do so either by binding to the Fn receptor or very near it, or instead, by binding to Fn or Fn fibrils in a self-assocation mode and altering the way in which this Fn complex regulates receptor activity. This could occur without displacing Fn or fibrils. In such a revised model, Fn would be required for Fn-f activity, similar to the requirement that Fn be present for binding of the N-terminal domain to cells 43 . Alternately, Fn-fs may bind to other non-Fn matrix components near Fn receptors and indirectly alter signalling without displacing Fn. It is also conceivable that Fn-fs could bind to or near unoccupied Fn receptors and cause an altered signal transduction pathway. Since in any of these scenarios, the Fn-fs would indirectly mediate their effects through the Fn receptor, our data cannot be used to confirm any of these pathways.
It might be predicted that Fn-f mediated disruption or modification of Fn interaction with a Fn receptor in chondrocytes would have diverse effects, based on other observations. For example, in the absence of attachment to Fn, integrin alpha 5 beta 1 expression activates a pathway leading to decreased cellular proliferation of HT29 colon carcinoma cells while ligation of receptor with Fn reverses this signal 50 . Further, disruption of binding of Fn to the alpha 5 beta 1 integrin stimulates cyclin dependent kinases and DNA synthesis and activation of MAP kinases 51 . Disruption of binding may also decrease Fn receptor content in the membrane. When attachment of substrate to the alpha 5 beta 1 integrins is blocked, the integrins become both internalized and degraded 52 . Thus, the overall mechanism for the action of the Fn-fs may be to destabilize Fn fibrils or block Fn interaction with the Fn receptor.
We have shown by a chemical cross-linking approach that all three Fn-fs and Fn bind close enough to the alpha 5 subunit to be chemically crosslinked (Homandberg et al., submitted) . The work reported here shows that this interaction might have functional significance since this subunit is required for the Fn-fs to exert their effects on PG synthesis suppression and MMP up-regulation. While we cannot rule out the additional involvement of other receptors, our work shows that the alpha 5 subunit should be a target for blocking the action of the Fn-fs. This may be crucial for blocking cartilage degeneration in OA, because of the likely physiologic relevance of Fn-fs in this disease.
